Details of the Target
General Information of Target
Target ID | LDTP03312 | |||||
---|---|---|---|---|---|---|
Target Name | Platelet-activating factor receptor (PTAFR) | |||||
Gene Name | PTAFR | |||||
Gene ID | 5724 | |||||
Synonyms |
PAFR; Platelet-activating factor receptor; PAF-R; PAFr |
|||||
3D Structure | ||||||
Sequence |
MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLT
MADMLFLITLPLWIVYYQNQGNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRFQAVT RPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGNVTRCFEHYEKG SVPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVQQQRNAEVKRRALWMVCTVLAV FIICFVPHHVVQLPWTLAELGFQDSKFHQAINDAHQVTLCLLSTNCVLDPVIYCFLTKKF RKHLTEKFYSMRSSRKCSRATTDTVTEVVVPFNQIPGNSLKN |
|||||
Target Type |
Successful
|
|||||
Target Bioclass |
GPCR
|
|||||
Family |
G-protein coupled receptor 1 family
|
|||||
Subcellular location |
Cell membrane
|
|||||
Function |
Receptor for platelet activating factor, a chemotactic phospholipid mediator that possesses potent inflammatory, smooth-muscle contractile and hypotensive activity. Seems to mediate its action via a G protein that activates a phosphatidylinositol-calcium second messenger system.
|
|||||
TTD ID | ||||||
Uniprot ID | ||||||
DrugMap ID | ||||||
Ensemble ID | ||||||
HGNC ID | ||||||
ChEMBL ID |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
IA-alkyne Probe Info |
![]() |
N.A. | LDD0166 | [1] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Enzyme
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Focal adhesion kinase 1 (PTK2) | Tyr protein kinase family | Q05397 |
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Rupatadine | Small molecular drug | DB11614 | |||
Ticlopidine | Small molecular drug | D05LBU |
Phase 4
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Rupatadine | Small molecular drug | D0S1CQ |
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Israpafant | Small molecular drug | D0D4ZM |
Phase 2
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Pegcntf | Small molecular drug | D0C2HI |
Investigative
Discontinued